---
title: "Edesa Biotech (Nasdaq: EDSA) reports Q1 2026 results, financials for three months ended December 31, 2025."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275947390.md"
description: "Today, Edesa Biotech, Inc. (Nasdaq:EDSA), a company specializing in host-directed therapeutics for immuno-inflammatory diseases, released financial data for the quarter ending December 31, 2025. The report also included a business update, highlighting their progress in the clinical-stage biopharmaceutical field."
datetime: "2026-02-13T21:22:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275947390.md)
  - [en](https://longbridge.com/en/news/275947390.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275947390.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275947390.md) | [繁體中文](https://longbridge.com/zh-HK/news/275947390.md)


# Edesa Biotech (Nasdaq: EDSA) reports Q1 2026 results, financials for three months ended December 31, 2025.

Today, Edesa Biotech, Inc. (Nasdaq:EDSA), a company specializing in host-directed therapeutics for immuno-inflammatory diseases, released financial data for the quarter ending December 31, 2025. The report also included a business update, highlighting their progress in the clinical-stage biopharmaceutical field.

### Related Stocks

- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [Edesa Biotech, Inc. (EDSA.US)](https://longbridge.com/en/quote/EDSA.US.md)

## Related News & Research

- [08:35 ETHalia Therapeutics Announces Presentation at the BIO Investment & Growth Summit](https://longbridge.com/en/news/277474512.md)
- [Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting | IRD Stock News](https://longbridge.com/en/news/277220357.md)
- [Bioventus beats Q4 revenue estimates on strong demand for pain treatments and surgical solutions](https://longbridge.com/en/news/277932436.md)
- [Xeris Biopharma Q4 product revenue beats analyst expectations, driven by higher patient demand](https://longbridge.com/en/news/277460502.md)
- [Veeva Systems Q4 revenue eases past estimates](https://longbridge.com/en/news/277834275.md)